ea0022p514 | Growth factors | ECE2010
Oclon Ewa
, Zubel Joanna
, Fedorczak Jacek
, Pierzchala-Koziec Krystyna
Metabolic syndrome (MS) is characterized by low-grade inflammation and determined as an increased risk for cardiovascular disease. Recently, reports have demonstrated the antiinflammatory effects of statins. Often, the inhibitor of HMG-CoA reductase called atorvastatin was used in these experiments.Therefore, the aim of the present study was to test the effect of atorvastatin (10 mg/day) on growth factors (ghrelin, IGF1) levels in piglets with MS. The ch...